Table 3

Associations between CGM satisfaction and change in QOL and glycemic control from baseline to 24-week follow-up (CGM group only)

CGM benefitsCGM hasslesCGM total satisfaction
B (SE)95% CIP valueB (SE)95% CIP valueB (SE)95% CIP value
Δ WHO-54.55 (2.57)−0.56 to 9.660.09−7.00 (2.39)−11.75 to −2.250.017.61 (2.80)2.05 to 13.170.02
Δ EQ-5D-5L0.02 (0.02)−0.02 to 0.050.38−0.04 (0.02)−0.08 to −0.010.030.04 (0.02)−0.01 to 0.080.08
Δ Diabetes distress (DDS)
 Total−0.18 (0.07)−0.32 to −0.040.020.31 (0.07)0.17 to 0.44<0.001−0.31 (0.08)−0.47 to −0.16<0.001
 Regimen−0.26 (0.11)−0.48 to −0.030.040.46 (0.10)0.25 to 0..66<0.001−0.46 (0.12)−0.70 to −0.22<0.001
 Emotional burden−0.23 (0.12)−0.48 to 0.020.080.47 (0.11)0.23 to 0.70<0.001−0.46 (0.13)−0.73 to −0.180.003
 Interpersonal0.03 (0.08)−0.14 to 0.190.740.07 (0.08)−0.10 to 0.220.43−0.03 (0.09)−0.21 to 0.160.79
 Physician−0.11 (0.05)−0.21 to −0.010.040.11 (0.05)0.02 to 0.210.03−0.14 (0.05)−0.24 to −0.020.02
Δ Hypoglycemic confidence (HCS)0.30 (0.09)0.11 to 0.480.003−0.44 (0.09)−0.62 to −0.26<0.0010.49 (0.10)0.29 to 0.70<0.001
Δ Hypoglycemia worry (HFS-II)−2.29 (1.56)−5.38 to 0.810.164.13 (1.50)1.15 to 7.110.02−4.22 (1.73)−7.66 to −0.780.03
Δ HbA1c−0.15 (0.15)−0.45 to 0.150.330.21 (0.15)−0.09 to 0.490.17−0.23 (0.17)−0.57 to 0.100.18
Δ % Time within range0.04 (0.03)−0.02 to 0.090.210.01 (0.03)−0.05 to 0.060.980.02 (0.03)−0.04 to 0.090.50
Δ % Time <70 mg/dL0.01 (0.01)−0.01 to 0.020.480.00 (0.01)−0.01 to 0.020.920.00 (0.01)−0.01 to 0.020.73
Δ % Time >180 mg/dL−0.04 (0.03)−0.10 to 0.020.210.01 (0.03)−0.06 to 0.060.88−0.03 (0.04)−0.11 to 0.050.43
  • Model values resulted from mixed linear regression models adjusted for baseline levels of the outcome (QOL and glycemic control) and clinical site as a random effect and participant demographic factors of age, sex, and number of years since diagnosis. P values are adjusted for multiple comparisons by using the Benjamini-Hochberg procedure. Δ, change.